A Synthesis of Clinical Research From Mahidol University 2019-2023

Abstract

Background: Strategic research funding is a potential avenue for financial support. Consequently, the synthesis of previous clinical research projects was conducted to explore the possibility of receiving funds. Objective: To synthesize the clinical research projects of Mahidol University. Methods: Research data synthesis was performed on clinical research projects in the database of the Research Management and Development Division, Mahidol University, covering the fiscal year 2019-2023. This synthesis was based on the strategic research funding of Thailand for the years 2023-2027 and the announcement of funding from the Program Management Unit (PMU) for the fiscal year 2023-2024. The results are reported by type classification, quantity, and percentage. Results: Clinical trial research conducted by Mahidol University during fiscal years 2019-2023, which met the criteria of the program for strategic research funding and qualified for the PMU’s announcement of research funding in the fiscal year 2023-2024, were as follows: 1) vaccine development and production, F1 (S1P1), 43 projects (81.13%); 2) development and production of advanced therapy medicinal products, F2 (S1P1), 15 projects (23.44%); 3) genomics and precision medicine, N1 (S1P1), 17 projects (94.44%); 4) development and production of medicines and herbal extracts, N2 (S1P1), 430 projects (97.28%); and 5) national epidemics and emerging diseases, N15 (S2P10), 11 projects (40.74%). Conclusions: Clinical trial research according to the program of strategic research funding and eligible for PMU was arranged in descending order as follows: N2 (S1P1), N1 (S1P1), F1 (S1P1), N15 (S2P10), and F2 (S1P1).